Ze Yu

1.1k total citations
52 papers, 764 citations indexed

About

Ze Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ze Yu has authored 52 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Ze Yu's work include Ferroptosis and cancer prognosis (7 papers), MicroRNA in disease regulation (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). Ze Yu is often cited by papers focused on Ferroptosis and cancer prognosis (7 papers), MicroRNA in disease regulation (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). Ze Yu collaborates with scholars based in China, United States and Pakistan. Ze Yu's co-authors include Chun‐Bo Teng, Sheng Tai, Yicheng Zhao, Hao Liang, Jin‐San Zhang, Yi Pan, Liang Jin, Mingjun Ma, Jia Liu and Qijia Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Ze Yu

45 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ze Yu China	16	381	265	160	140	103	52	764
Jiaming Xie China	13	515 1.4×	291 1.1×	170 1.1×	186 1.3×	117 1.1×	35	977
Yukiko Nishiguchi Japan	20	401 1.1×	236 0.9×	208 1.3×	146 1.0×	82 0.8×	45	837
Shiori Mori Japan	19	396 1.0×	255 1.0×	152 0.9×	135 1.0×	51 0.5×	52	802
Kunishige Onuma Japan	18	349 0.9×	197 0.7×	258 1.6×	126 0.9×	74 0.7×	37	899
Rina Fujiwara‐Tani Japan	20	447 1.2×	308 1.2×	173 1.1×	138 1.0×	56 0.5×	63	902
Kyung Hee Koo South Korea	9	487 1.3×	245 0.9×	194 1.2×	84 0.6×	64 0.6×	11	760
Xue Leng China	15	713 1.9×	362 1.4×	212 1.3×	156 1.1×	101 1.0×	30	980
Fandong Meng China	15	475 1.2×	208 0.8×	123 0.8×	75 0.5×	118 1.1×	30	740
Yu Zeng China	17	590 1.5×	277 1.0×	164 1.0×	117 0.8×	105 1.0×	47	858
Yiting Tang China	17	637 1.7×	301 1.1×	105 0.7×	82 0.6×	120 1.2×	31	965

Countries citing papers authored by Ze Yu

Since Specialization

Citations

This map shows the geographic impact of Ze Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze Yu more than expected).

Fields of papers citing papers by Ze Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze Yu. The network helps show where Ze Yu may publish in the future.

Co-authorship network of co-authors of Ze Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ze Yu. A scholar is included among the top collaborators of Ze Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ze Yu. Ze Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Kuan, et al.. (2025). Prevalence of Insomnia and Related Factors Among Cancer Outpatients in China. Nature and Science of Sleep. Volume 17. 69–79. 2 indexed citations

Li, Ziqi, et al.. (2025). Involvement of ACSM family genes in the reprogramming of lipid metabolism within tumors and their investigation as promising therapeutic targets. Frontiers in Cell and Developmental Biology. 13. 1663033–1663033.

Zheng, Lei, D. P. Jin, Hongwei Yu, Ze Yu, & Linmao Qian. (2025). Application of AI in the identification of gastrointestinal stromal tumors: a comprehensive analysis based on pathological, radiological, and genetic variation features. Frontiers in Genetics. 16. 1555744–1555744.

Jiang, Yixiao, Ze Yu, Jie Wang, et al.. (2025). Targeting USP47 enhances immunotherapy in hepatocellular carcinoma by destabilizing PD-L1. International Immunopharmacology. 161. 115024–115024.

Zhao, Kuan, et al.. (2024). Efficacy comparison of five antidepressants in treating anxiety and depression in cancer and non-cancer patients. Frontiers in Neuroscience. 18. 1485179–1485179. 3 indexed citations

Yu, Hai‐Fan, Qing‐Yin Zeng, Ping Yue, et al.. (2024). Hippo-YAP signaling alleviates copper-induced mitochondrial dysfunction and oxidative damage via the ATOX1-PPA2 pathway. International Journal of Biological Macromolecules. 290. 138908–138908. 1 indexed citations

Yu, Ze, et al.. (2024). SIRT3 Inhibits Cell Proliferation of Nonsmall Cell Lung Carcinoma by Inducing ROS Production. The Clinical Respiratory Journal. 18(11). e70033–e70033.

Yu, Ze, Yixiao Jiang, Ting Le, et al.. (2024). Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway. Frontiers in Bioscience-Landmark. 29(1). 35–35. 4 indexed citations

Wang, Hongqiang, et al.. (2024). Deficiency of TOP1MT enhances glycolysis through the stimulation of PDK4 expression in gastric cancer. SHILAP Revista de lepidopterología. 12(1). 2–2. 3 indexed citations

10.

Jiang, Dongyang, Hao Liu, Guofu Zhu, et al.. (2023). Endothelial PHACTR1 Promotes Endothelial Activation and Atherosclerosis by Repressing PPARγ Activity Under Disturbed Flow in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 43(8). e303–e322. 10 indexed citations

11.

Zhang, Ruonan, Jie Wang, Yu Du, et al.. (2023). CDK5 destabilizes PD-L1 via chaperon-mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 11(11). e007529–e007529. 18 indexed citations

12.

Jin, Jing, Mingjun Ma, Jiaru Wang, et al.. (2022). Copper enhances genotoxic drug resistance via ATOX1 activated DNA damage repair. Cancer Letters. 536. 215651–215651. 43 indexed citations

13.

Li, Huan, Jie Zhang, Ze Yu, et al.. (2022). Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis. Cell Reports. 41(12). 111834–111834. 11 indexed citations

14.

Feng, Wei, Ze Yu, Shunying Yu, et al.. (2020). No association between the COMT Val158Met polymorphism and cognitive training response in healthy Shanghai community-dwelling elderly individuals. Annals of Palliative Medicine. 9(4). 1396–1403. 1 indexed citations

15.

Li, Huan, Ze Yu, Run Shi, et al.. (2020). Tumor Necrosis Factor α Reduces SNAP29 Dependent Autolysosome Formation to Increase Prion Protein Level and Promote Tumor Cell Migration. Virologica Sinica. 36(3). 458–475. 8 indexed citations

16.

Li, Jingwen, Yukai Jing, Lu Yang, et al.. (2019). The Coordination Between B Cell Receptor Signaling and the Actin Cytoskeleton During B Cell Activation. Frontiers in Immunology. 9. 3096–3096. 53 indexed citations

17.

Cheng, Jiali, Yukai Jing, Lu Yang, et al.. (2018). The Role of Mst1 in Lymphocyte Homeostasis and Function. Frontiers in Immunology. 9. 149–149. 18 indexed citations

18.

Zhu, Guofu, Ying Lin, Hao Liu, et al.. (2018). Dll4-Notch1 signaling but not VEGF-A is essential for hyperoxia induced vessel regression in retina. Biochemical and Biophysical Research Communications. 507(1-4). 400–406. 6 indexed citations

19.

Wang, Ping, et al.. (2017). miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway. DNA and Cell Biology. 37(1). 38–45. 45 indexed citations

20.

Yu, Ze, et al.. (2015). Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol. Molecular Medicine Reports. 11(6). 4727–4733. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact